Editorial

COVID 19: Natural Products and Traditional Medicines; Opportunity or Threat?

Abstract

No Abstract.No Abstract.No Abstract.No Abstract.No Abstract.

WHO. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. March 11, 2020. https://www. who.int/dg/speeches/detail/who-directorgeneral-s-opening-remarks-at-the-mediabriefing-on-covid-19---11-march-2020 (accessed March 20, 2020).

Chang Z. The discovery of Qinghaosu (artemisinin) as an effective anti-malaria drug: A unique China story. Sci China Life Sci 2016;59:81-8.

Owens B. 2015 Nobel Prize goes to antiparasitic drug discoverers. Lancet 2015;386:1433.

Xie J et al. Critical care crisis and some recommendations during the COVID-19 epidemic in China. Intensive Care Med 2020;46:837-840.

Ryu HS, Oh HK, Lee JY, Yoon SW. An Overview on the Traditional Chinese Medicine Treatment Guidelines for Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). J Intern Korean Med 2015;36:335-347.

Cui HT et al. Traditional chinese medicine for treatment of coronavirus disease 2019: a review. Trad Med Res 2020;5:65-73.

Zhang D, Wu K, Zhang X, Deng S, Peng B. In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. J Integr Med 2020;18:152-158.

Files
IssueVol 6, No 1, 2021 QRcode
SectionEditorial
DOI https://doi.org/10.18502/tim.v6i1.5922
Keywords
Corona virus Integrative Medicine Complementary medicine
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Zargaran A, Karimi M, Rezaeizadeh H. COVID 19: Natural Products and Traditional Medicines; Opportunity or Threat?. Trad Integr Med. 2021;6(1):1-2.